Evidence map›Paper›PMID 41788804›Full record

ArticleFrontiers in pharmacology2026

Peptide-based antimicrobial effect against carbapenem-resistant

Hak Jun Lee, Seung Jun Lee, Yoon Hyun Sung, Seung Min Park, Seung Pyo Choi, Yangmee Kim, Young Kyung Yoon

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Hak Jun LeeInstitute of Emerging Infectious Diseases, Korea University, Seoul, Republic of Korea.
Seung Jun LeeR&D Team, HLB Science, Seoul, Republic of Korea.
Yoon Hyun SungInstitute of Emerging Infectious Diseases, Korea University, Seoul, Republic of Korea.
Seung Min ParkInstitute of Emerging Infectious Diseases, Korea University, Seoul, Republic of Korea.
Seung Pyo ChoiR&D Team, HLB Science, Seoul, Republic of Korea.
Yangmee KimDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, Republic of Korea.
Young Kyung YoonInstitute of Emerging Infectious Diseases, Korea University, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carbapenem-resistant Methods: Results: In both the checkerboard method and time-kill assay, DD-S052P demonstrated Conclusion: Our findings indicate that DD-S052P in combination with colistin may represent a promising therapeutic option for CRAB infections. Further research is required to elucidate the mechanisms by which DD-S052P overcomes existing carbapenem resistance and validate its clinical applicability.

Indexed as

Acinetobacter baumanniianimal modelantimicrobial peptidescarbapenem-resistantcombination therapy

Identifiers

PMID41788804
PMCPMC12957892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.